🇺🇸 Omvoh in United States

FDA authorised Omvoh on 29 April 2024

Marketing authorisation

FDA — authorised 29 April 2024

Application: BLA761279
Marketing authorisation holder: ELI LILLY AND CO
Indication: Labeling
Status: approved

The FDA granted marketing authorisation to Omvoh, a product of Eli Lilly and Company, on 29 April 2024. The marketing authorisation was granted through a standard expedited pathway. The approved indication for Omvoh is listed in its labelling, but the specific indication is not reported in the available data.

Read official source →

Omvoh in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Immunology approved in United States

Frequently asked questions

Is Omvoh approved in United States?

Yes. FDA authorised it on 29 April 2024.

Who is the marketing authorisation holder for Omvoh in United States?

ELI LILLY AND CO holds the US marketing authorisation.